Kang Jun-Myung, Auo Hyeon-Jin, Yoo Young-Hwa, Cho Jin-Hee, Kim Byung-Guk
Department of Otolaryngology-HNS, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Int J Pediatr Otorhinolaryngol. 2008 Jul;72(7):1065-9. doi: 10.1016/j.ijporl.2008.03.015. Epub 2008 May 5.
Adenotonsillar hypertrophy can cause upper airway obstruction and may be associated with growth delay in children. The objective of this study was to evaluate the long-term effects of adenotonsillectomy on height, weight, and body mass index (BMI) in children with sleep-disordered breathing (SDB).
Fifty-two children (mean age 6.2+/-2.3 years) clinically diagnosed with SDB were enrolled. Children were diagnosed and scheduled for adenotonsillectomy (T&A) based on their responses to the validated, 22-item Sleep Related Breathing Disorder (SRDB) scale and a physical examination that showed adenotonsillar hypertrophy. Weight, height, and BMI were evaluated before and 5 years after T&A. Serum levels of insulin-like growth factor-1 (IGF-1) were measured before and 1 month after T&A.
Serum levels of IGF-1 were significantly higher at 1 month after T&A compared to before T&A (p<0.001). Thirty children (58%) returned for follow-up testing 5 years later. Their Z scores (standard deviation scores) for weight, height, and BMI of 30 children were significantly higher 5 years after T&A compared to before T&A (p<0.01).
Children with SDB who undergo adenotonsillectomy show significant, long-term increases in weight, height and BMI, as well as a significant increase in serum levels of IGF-1.
腺样体扁桃体肥大可导致上气道阻塞,并可能与儿童生长发育迟缓有关。本研究的目的是评估腺样体扁桃体切除术对睡眠呼吸障碍(SDB)儿童身高、体重和体重指数(BMI)的长期影响。
纳入52例临床诊断为SDB的儿童(平均年龄6.2±2.3岁)。根据他们对经过验证的22项睡眠相关呼吸障碍(SRDB)量表的回答以及显示腺样体扁桃体肥大的体格检查结果,对儿童进行诊断并安排腺样体扁桃体切除术(T&A)。在T&A术前和术后5年评估体重、身高和BMI。在T&A术前和术后1个月测量血清胰岛素样生长因子-1(IGF-1)水平。
与T&A术前相比,T&A术后1个月时血清IGF-1水平显著升高(p<0.001)。5年后,30名儿童(58%)返回进行随访测试。与T&A术前相比,30名儿童术后5年的体重、身高和BMI的Z评分(标准差评分)显著更高(p<0.01)。
接受腺样体扁桃体切除术的SDB儿童在体重、身高和BMI方面显示出显著的长期增加,血清IGF-1水平也显著升高。